Cargando…

Retinal Examination Modalities in the Early Detection of Alzheimer's Disease: Seeing Brain Through the Eye

Detalles Bibliográficos
Autores principales:	Ma, Xiaoxi, Wang, Xi, Xiao, Yiqin, Zhao, Qianhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901549/ https://www.ncbi.nlm.nih.gov/pubmed/36776234 http://dx.doi.org/10.2478/jtim-2021-0053

Ejemplares similares

Recent advancements toward non-invasive imaging of retinal amyloid-beta for early detection of Alzheimer’s disease
por: Wang, Liang, et al.
Publicado: (2022)

Active immunotherapy and alternative therapeutic modalities for Alzheimer's disease
por: Weninger, Stacie, et al.
Publicado: (2020)

Perifovea retinal thickness as an ophthalmic biomarker for mild cognitive impairment and early Alzheimer's disease
por: Tao, Rui, et al.
Publicado: (2019)

Two-eyed seeing: Embracing the power of Indigenous knowledge for a healthy and sustainable Ocean
por: Leonard, Kelsey, et al.
Publicado: (2022)

Seeing COVID-19 through José Saramago's Blindness
por: Marchalik, Daniel, et al.
Publicado: (2020)

The Migrainous Brain: What You See Is Not All You Get?
por: Goadsby, Peter J
Publicado: (2006)

Alzheimer’s Retinopathy: Seeing Disease in the Eyes
por: Mirzaei, Nazanin, et al.
Publicado: (2020)

Transcranial photobiomodulation with near-infrared light: a promising therapeutic modality for Alzheimer’s disease
por: Liu, Hanli, et al.
Publicado: (2023)

Brain insulin resistance: an early risk factor for Alzheimer's disease development in Down syndrome
por: Barone, Eugenio
Publicado: (2021)

Guardians of the eye: new tales about retinal microglia and other ocular macrophages
por: Rosmus, Dennis-Dominik, et al.
Publicado: (2021)

Complement pathway in Alzheimer’s pathology and retinal neurodegenerative disorders – the road ahead
por: Mirzaei, Mehdi, et al.
Publicado: (2019)

Converging multi-modality datasets to build efficient drug repositioning pipelines against Alzheimer’s disease and related dementias
por: Yin, Zheng, et al.
Publicado: (2022)

Perspective: Seeing the Forest Through the Trees: The Importance of Food Matrix in Diet Quality and Human Health
por: Miller, Gregory D., et al.
Publicado: (2023)

Sepsis: An Evolutionary Perspective (Sepsis through the Eyes of a Microbe vs Clinical Sepsis through the Eyes of an Intensivist)
por: Kapadia, Farhad N
Publicado: (2020)

While You Don’t See Color, I See Bias: Identifying Barriers in Access to Graduate Medical Education Training
por: Tatem, Geneva B., et al.
Publicado: (2021)

CyberEye: New Eye-Tracking Interfaces for Assessment and Modulation of Cognitive Functions beyond the Brain
por: Lech, Michał, et al.
Publicado: (2021)

Ros Taylor: seeing palliative care as relational
por: Samarasekera, Udani
Publicado: (2022)

Seeing is believing: the impact of RB on nuclear organization
por: Krishnan, Badri, et al.
Publicado: (2023)

Seeing is believing: The development of optical coherence tomography
por: Nathans, Jeremy
Publicado: (2023)

Seeing it through: translational validation of new medical imaging modalities
por: Aldrich, Melissa B., et al.
Publicado: (2012)

Brain ischemia as a bridge to Alzheimer’s disease
por: Pluta, Ryszard
Publicado: (2021)

Decreased Retinal Vascular Density in Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI): An Optical Coherence Tomography Angiography (OCTA) Study
por: Wang, Xi, et al.
Publicado: (2021)

Editorial: Seeing Beyond the Eye: The Brain Connection
por: Nguyen, Christine T. O., et al.
Publicado: (2021)

A questionnaire-based assessment of Safe Eye Examination (SEE) technique
por: Mishra, Divyansh, et al.
Publicado: (2021)

Seeing the Forest for the Trees: A Medical Education Focused on Concepts
por: Agusala, Kartik
Publicado: (2021)

Early HIV Infection in the United States: A Virus's Eye View
por: Hallett, Timothy B.
Publicado: (2013)

Discerning the Role of Blood Brain Barrier Dysfunction in Alzheimer’s Disease
por: Tao, Qing-Qing, et al.
Publicado: (2022)

Recruiting to preclinical Alzheimer's disease clinical trials through registries
por: Grill, Joshua D.
Publicado: (2017)

Nose-to-brain drug delivery approach: a key to easily accessing the brain for the treatment of Alzheimer's disease
por: Alexander, Amit, et al.
Publicado: (2018)

Is blood-brain barrier a probable mediator of non-invasive brain stimulation effects on Alzheimer’s disease?
por: Petrovskaya, Aleksandra, et al.
Publicado: (2023)

Brain network modulation in Alzheimer’s disease: clinical phenotypes and windows of opportunity
por: Pini, Lorenzo
Publicado: (2022)

An Insider View of the Cancer Radiation Experience Through the Eyes of a Cancer Patient
por: Leotin, Sylvie
Publicado: (2019)

The Longitudinal Early‐onset Alzheimer's Disease Study (LEADS): Framework and methodology
por: Apostolova, Liana G., et al.
Publicado: (2021)

Commentary: A questionnaire-based assessment of Safe Eye Examination (SEE) technique
por: Bhagat, Purvi R
Publicado: (2021)

Commentary: A questionnaire-based assessment of Safe Eye Examination (SEE) technique
por: Joshi, Shrinivas, et al.
Publicado: (2021)

The magical maze: seeing the world through mathematical eyes
por: Stewart, Ian
Publicado: (1997)

Eye-brain axis in microgravity and its implications for Spaceflight Associated Neuro-ocular Syndrome
por: Stern, Claudia, et al.
Publicado: (2023)

The brain compensatory mechanisms and Alzheimer's disease progression: a new protective strategy
por: Bobkova, Natalia, et al.
Publicado: (2015)

The blood-brain barrier models to study apolipoprotein E genotypes in Alzheimer's disease
por: Dias, Irundika HK, et al.
Publicado: (2022)

The Golgi apparatus: Site for convergence of COVID-19 brain fog and Alzheimer’s disease?
por: Wang, Yanzhuang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rgin1g18dltjhu1d5i6j69386h